AP2014008162A0 - Pharmaceutical composition for treatment of the pulmonary form of altitude sickness caused by lack of oxygen and reduced air pressure - Google Patents
Pharmaceutical composition for treatment of the pulmonary form of altitude sickness caused by lack of oxygen and reduced air pressureInfo
- Publication number
- AP2014008162A0 AP2014008162A0 AP2014008162A AP2014008162A AP2014008162A0 AP 2014008162 A0 AP2014008162 A0 AP 2014008162A0 AP 2014008162 A AP2014008162 A AP 2014008162A AP 2014008162 A AP2014008162 A AP 2014008162A AP 2014008162 A0 AP2014008162 A0 AP 2014008162A0
- Authority
- AP
- ARIPO
- Prior art keywords
- lack
- oxygen
- treatment
- pharmaceutical composition
- air pressure
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12173983.3A EP2679239A1 (de) | 2012-06-28 | 2012-06-28 | Pharmazeutische Zusammensetzung zur Behandlung der durch Sauerstoffarmut und verringerten Luftdruck vermittelten pulmonalen Form der Höhenkrankheit |
| PCT/EP2013/062777 WO2014001177A1 (de) | 2012-06-28 | 2013-06-19 | Pharmazeutische zusammensetzung zur behandlung der durch sauerstoffarmut und verringerten luftdruck vermittelten pulmonalen form der höhenkrankheit |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AP2014008162A0 true AP2014008162A0 (en) | 2014-12-31 |
Family
ID=48672620
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AP2014008162A AP2014008162A0 (en) | 2012-06-28 | 2013-06-19 | Pharmaceutical composition for treatment of the pulmonary form of altitude sickness caused by lack of oxygen and reduced air pressure |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US9802985B2 (xx) |
| EP (2) | EP2679239A1 (xx) |
| JP (1) | JP6113277B2 (xx) |
| KR (1) | KR102010793B1 (xx) |
| CN (1) | CN104427993B (xx) |
| AP (1) | AP2014008162A0 (xx) |
| AU (1) | AU2013283563B2 (xx) |
| CA (1) | CA2875749C (xx) |
| EA (1) | EA030384B1 (xx) |
| ES (1) | ES2602197T3 (xx) |
| IN (1) | IN2015DN00585A (xx) |
| MX (1) | MX354302B (xx) |
| PE (1) | PE20150198A1 (xx) |
| WO (1) | WO2014001177A1 (xx) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2939635A1 (en) * | 2014-03-04 | 2015-09-11 | Apeptico Forschung Und Entwicklung Gmbh | Attenuation of intrapulmonary inflammation |
| EP3062772B1 (en) * | 2014-03-18 | 2018-01-24 | APEPTICO Forschung und Entwicklung GmbH | Dry-powder peptide medicament |
| WO2017064577A1 (en) | 2015-08-25 | 2017-04-20 | Bar-Ilan University | Asymmetric electrochemical cell apparatus, and operating methods thereof |
| WO2018211474A1 (en) | 2017-05-19 | 2018-11-22 | Trudell Medical International | Positive expiratory pressure device |
| USD903097S1 (en) | 2018-05-18 | 2020-11-24 | Trudell Medical International | Mask |
| USD874064S1 (en) | 2018-05-18 | 2020-01-28 | Trudell Medical International | Mask |
| USD893806S1 (en) | 2018-11-09 | 2020-08-18 | Trudell Medical Internationl | Mask and shroud |
| EP4051311A4 (en) * | 2019-10-29 | 2023-12-06 | University of Pittsburgh - of the Commonwealth System of Higher Education | LUNG-SPECIFIC TARGETING PEPTIDE (LTP), COMPOSITIONS AND USES THEREOF |
| EP4051307B1 (en) | 2020-05-08 | 2023-02-01 | APEPTICO Forschung und Entwicklung GmbH | Peptide for prevention or treatment of covid-19 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4069819A (en) | 1973-04-13 | 1978-01-24 | Societa Farmaceutici S.P.A. | Inhalation device |
| IT1228459B (it) | 1989-02-23 | 1991-06-19 | Phidea S R L | Inalatore con svuotamento regolare e completo della capsula. |
| EP0682705A1 (en) | 1993-02-03 | 1995-11-22 | N.V. Innogenetics S.A. | Tnf-alpha muteins and a process for preparing them |
| EP1105152A1 (en) * | 1998-08-14 | 2001-06-13 | Innogenetics N.V. | Tnf-derived peptides for use in treating oedema |
| EP1781323B1 (en) * | 2004-08-06 | 2010-02-17 | Nycomed GmbH | Composition comprising a pulmonary surfactant and a tnf-derived peptide |
| EP2009023A1 (en) | 2007-06-04 | 2008-12-31 | Rentschler Beteiligungs GmbH | Novel peptides and their use for the treatment of edema |
| AT506150B1 (de) | 2007-12-12 | 2010-01-15 | Apeptico Forschung Und Entwick | Zyklisches und cystein-freies peptid |
| WO2010102148A2 (en) * | 2009-03-04 | 2010-09-10 | Mannkind Corporation | An improved dry powder drug delivery system |
| AT507953B1 (de) * | 2009-03-05 | 2011-02-15 | Apeptico Forschung & Entwicklung Gmbh | Verfahren zur vermeidung und zur behandlung einer hyperpermeabilität |
| AT509267A1 (de) | 2010-01-14 | 2011-07-15 | Apeptico Forschung & Entwicklung Gmbh | Organische verbindungen zur regulierung von vektoriellen ionenkanälen |
| AT510585B1 (de) | 2010-11-18 | 2012-05-15 | Apeptico Forschung & Entwicklung Gmbh | Zusammensetzung umfassend ein peptid und ein hemmstoff der viralen neuraminidase |
-
2012
- 2012-06-28 EP EP12173983.3A patent/EP2679239A1/de not_active Withdrawn
-
2013
- 2013-06-19 MX MX2014015048A patent/MX354302B/es active IP Right Grant
- 2013-06-19 PE PE2014002486A patent/PE20150198A1/es not_active Application Discontinuation
- 2013-06-19 EP EP13730877.1A patent/EP2866824B1/de active Active
- 2013-06-19 IN IN585DEN2015 patent/IN2015DN00585A/en unknown
- 2013-06-19 CN CN201380033379.XA patent/CN104427993B/zh active Active
- 2013-06-19 KR KR1020157000350A patent/KR102010793B1/ko active IP Right Grant
- 2013-06-19 AU AU2013283563A patent/AU2013283563B2/en not_active Ceased
- 2013-06-19 JP JP2015518983A patent/JP6113277B2/ja active Active
- 2013-06-19 WO PCT/EP2013/062777 patent/WO2014001177A1/de active Application Filing
- 2013-06-19 US US14/410,642 patent/US9802985B2/en active Active
- 2013-06-19 ES ES13730877.1T patent/ES2602197T3/es active Active
- 2013-06-19 CA CA2875749A patent/CA2875749C/en active Active
- 2013-06-19 EA EA201500061A patent/EA030384B1/ru unknown
- 2013-06-19 AP AP2014008162A patent/AP2014008162A0/xx unknown
-
2017
- 2017-09-25 US US15/714,111 patent/US20190211061A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| IN2015DN00585A (xx) | 2015-06-26 |
| WO2014001177A1 (de) | 2014-01-03 |
| EP2866824A1 (de) | 2015-05-06 |
| CA2875749A1 (en) | 2014-01-03 |
| JP2015526399A (ja) | 2015-09-10 |
| MX354302B (es) | 2018-02-23 |
| KR102010793B1 (ko) | 2019-08-14 |
| KR20150037815A (ko) | 2015-04-08 |
| MX2014015048A (es) | 2015-06-05 |
| PE20150198A1 (es) | 2015-02-19 |
| CN104427993A (zh) | 2015-03-18 |
| EA201500061A1 (ru) | 2015-06-30 |
| CN104427993B (zh) | 2017-03-08 |
| US20190211061A1 (en) | 2019-07-11 |
| ES2602197T3 (es) | 2017-02-20 |
| US20150225460A1 (en) | 2015-08-13 |
| CA2875749C (en) | 2019-02-26 |
| EA030384B1 (ru) | 2018-07-31 |
| EP2679239A1 (de) | 2014-01-01 |
| EP2866824B1 (de) | 2016-08-10 |
| US9802985B2 (en) | 2017-10-31 |
| JP6113277B2 (ja) | 2017-04-12 |
| AU2013283563B2 (en) | 2017-06-08 |
| AU2013283563A1 (en) | 2015-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1255336A1 (zh) | 藥物製劑及其製備方法 | |
| AP2014008162A0 (en) | Pharmaceutical composition for treatment of the pulmonary form of altitude sickness caused by lack of oxygen and reduced air pressure | |
| ZA201500593B (en) | Activators of ampk and therapeutic uses thereof | |
| IL238204A0 (en) | Methods and systems for transporting oxygen-enriched gas | |
| HK1215861A1 (zh) | 用於治療高鈣血症患者高鉀血症的微孔硅酸鋯以及用於治療高鉀血症的改進的含鈣組合物 | |
| IL238538A0 (en) | Porous silica material for use as a pharmaceutical or nutritional active ingredient | |
| GB201222455D0 (en) | Novel pharmaceutical formulations and their use in the treatment of periodontaldisease | |
| HK1203149A1 (en) | Novel dosage form and formulation of abediterol | |
| EP2594283A4 (de) | Aerosolpräparat auf aprotininbasis zur behandlung von virusinfektionen der atemwege | |
| EP2841559A4 (en) | GLYCOMODIFIED EXTERNAL MEMBRANE VESICLES AND THEIR USE AS VACCINES | |
| PL2874600T3 (pl) | Kompozycja farmaceutyczna do leczenia chrypki lub bólów gardła. | |
| HK1188791A1 (zh) | 新型八氫噻吩並喹啉衍生物、包含所述衍生物的藥物組合物及它們的用途 | |
| GB2504390B (en) | Nutraceutical and pharmaceutical composition | |
| AU339359S (en) | Respiratory mask and/or components thereof | |
| PL2812058T3 (pl) | Urządzenie do regulacji przepływu tlenu i/lub powietrza do końcówek donosowych | |
| HK1204289A1 (en) | Topical ophthalmological pharmaceutical composition containing cediranib | |
| ZA201308905B (en) | Nasal pharmaceutical formulation comprising fluticasone | |
| IL233961A0 (en) | The composition of a phytogenic supplement and methods of its use | |
| EP2866792A4 (en) | MICROPARTICLE FORMULATIONS FOR DELIVERY TO LOWER AND CENTRAL RESPIRATORY PATHS AND METHOD OF PREPARING THEM | |
| PT2846806T (pt) | Tratamento para depressão respiratória | |
| EP2861586A4 (en) | FORMS OF VILAZODONE AND METHODS OF PREPARATION THEREOF | |
| HUP1200552A2 (en) | Pharmaceutical compositions for the treatment of high blood pressure | |
| EG27014A (en) | Apparatus for clearing the air from CO2 convertingit to oxygen and sterilize the air | |
| WO2013109213A3 (en) | Pharmaceutical formulations comprising tiotropium | |
| GB201207064D0 (en) | Pharmaceutical compositions comprising 15-hetre and methods of using the same |